C
Palisades Goldcorp Ltd. PALI.V
TSX
Recommendation
Prev Close
$1.90
Volume
--
Avg Vol (90D)
53,432
Market Cap
$88.89M
Dividend & Yield
--
52-Week Range
$0.84 - $2.35
P/E (TTM)
11.11
EPS (TTM)
$0.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Palisade Bio Inc
12/13/2025 - GuruFocus
Palisade Bio (NASDAQ:PALI) Trading Up 0.6% - Here's What Happened
12/9/2025 - MarketBeat
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as ...
12/2/2025 - GuruFocus
Palisade Bio appoints James Izanec as VP, clinical development
12/2/2025 - The Fly
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development
12/2/2025 - Globe Newswire
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
11/25/2025 - GuruFocus
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
11/25/2025 - Globe Newswire
Individual investors are Palisade Bio, Inc.'s (NASDAQ:PALI) biggest owners and were rewarded after market cap rose by US$70m last week
11/21/2025 - Simply Wall St
FY2025 EPS Estimate for Palisade Bio Increased by Analyst
11/17/2025 - MarketBeat
Palisade Bio (PALI) Price Target Increased by 45.83% to 11.90
11/17/2025 - Nasdaq News: Stocks
Palisade Bio (NASDAQ:PALI) Announces Earnings Results, Misses Estimates By $0.06 EPS
11/11/2025 - MarketBeat
Palisade Bio price target raised to $8 from $2 at Maxim
11/11/2025 - TipRanks Financial Blog
Palisade Bio price target raised by $6 at Maxim, here's why
11/11/2025 - The Fly
Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher
11/10/2025 - Zacks Investment Research
All You Need to Know About Palisade Bio (PALI) Rating Upgrade to Buy
11/6/2025 - Zacks Investment Research
Short Interest in Palisade Bio, Inc. (NASDAQ:PALI) Rises By 469.2%
10/30/2025 - Ticker Report
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
10/28/2025 - GuruFocus
Palisade Bio appoints Sharon Skare as global head, clinical operations
10/28/2025 - TipRanks Financial Blog
Palisade Bio appoints Sharon Skare as global head, clinical operations
10/28/2025 - The Fly
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
10/28/2025 - Globe Newswire
Palisade Bio Terminates Phantom Unit Plan
10/22/2025 - TipRanks Financial Blog
Steve Cohen's Point72 Buys $20M of Surging Biotech Stock That Recently Priced $125M Offering to Advance Myeloma Treatment
10/21/2025 - IB Times - Companies
Palisade Bio Approves Reverse Stock Split Amendment
10/20/2025 - TipRanks Financial Blog
Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 ...
10/20/2025 - GuruFocus
Palisade Bio (PALI) Begins Phase 1b Study on Novel Crohn's Disease Treatment
10/20/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$93.07M
EBITDA (TTM)
$91.33M
EBIT (TTM)
$88.74M
Net Income (TTM)
$29.01M
Balance Sheet
Total Assets (Q)
$183.25M
Total Debt (Q)
$12.02M
Total Liabilities (Q)
$49.29M
Book Value Per Share (Q)
$2.08
Cash Flow
Cash from Operations (TTM)
-$7.64M
Cash from Investing (TTM)
-$303.60K
Cash from Financing (TTM)
$13.65M
Net Change in Cash (TTM)
$5.71M
Filings
Filing Date
Tuesday, November 11, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Apr 6 and 10 (est)
Price History
Loading...
Beta
0.63
7-Day Total Return
-17.68%
30-Day Total Return
-5.10%
60-Day Total Return
-9.15%
90-Day Total Return
4.20%
Year to Date Total Return
-3.93%
1-Year Total Return
4.20%
2-Year Total Return
-31.32%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
May 20, 2025 - $0.84
52-week High
Feb 11, 2025 - $2.35
Valuation
Market Cap
$88.89M - Micro Cap
Enterprise Value
-$24.29M
Price/Sales (TTM)
1.47
Price/Book (Q)
0.91
Dividends and Shares
Shares Outstanding
71.83
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
palisades.ca
Phone Number
Address
700 West Georgia Street
Vancouver, BC V7Y 1B3
Country
Canada
Year Founded
2019
Business Description
Sector
Financials
Industry
Financial Services
Palisades Goldcorp Ltd., a resource investment company and merchant bank, focuses on investing in junior companies in the resource and mining sector. The company was incorporated in 2019 and is... more